Dr. Bishoy G. Kamel, MD

Dr. Kamel practices at St. Francis Medical Center in Lynwood, California, part of Prime Healthcare Services.

Dr. Kamel's NPI, 1992169643, was assigned on April 8, 2016. Dr. Kamel graduated from Ain Shams University Faculty of Medicine in 2004. Dr. Kamel holds California license A156933.

Dr. Kamel's primary practice is St. Francis Medical Center, at 3630 East Imperial Highway, Lynwood, CA 90262 in Los Angeles County. The practice phone is (310) 900-8900.

Dr. Kamel's primary practice is St. Francis Medical Center in Lynwood, California, part of Prime Healthcare Services. Dr. Kamel is also affiliated with Adventist Health White Memorial. The medical group on file is Epic Medical Group. Dmand AI also links Dr. Kamel to 3 more hospitals, 5 skilled nursing facilities, 3 medical groups and 2 home health agencies, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kamel practices, 12 sites in all. Vendor and product names are available with a free account.

General practice is Dr. Kamel's primary specialty in the NPI Registry, under taxonomy code 208D00000X. Dr. Kamel is licensed in California.

Dmand AI lists acid reflux, acute diabetes, acute respiratory failure, asthma, atherosclerosis, atrial fibrillation and flutter, bile duct problems and cardiac arrhythmia among the conditions Dr. Kamel treats.

CMS data shows 9,349 Medicare services from Dr. Kamel across 12 procedure codes in 2024, for 552 Medicare patients. Medicare paid $843,851 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 552 Medicare patients who saw Dr. Kamel in 2024. The largest group is 65 to 74, with 189 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 89% are also on Medicaid. Their average risk score is 3.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kamel's median patient age at 61, with 46% women.

In 2024, Dr. Kamel wrote 4,541 Medicare Part D claims for 293 patients. 85% of them were for generic drugs. CMS names the drug for 3,914 of them, across 101 drugs with 11 or more claims each, at $284,559 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kamel for performance year 2024, reported individually. Dr. Kamel accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 20 papers to Dr. Kamel, published from 2015 to 2022. 2015 was the busiest year, with 3. The most frequent topics are Febuxostat, Gout and Phylogeny. Dr. Kamel has published most often in PLoS Negl Trop Dis. Dr. Kamel's most frequent co-authors are Fortunay Diatta, MD, Guilherme H. Oliveira, MD and Jessica Kathleen Sassic, MD.

Dr. Kamel graduated from Ain Shams University Faculty of Medicine in 2004.

Dr. Kamel is in network with 5 carriers, including Blue Cross Blue Shield of Massachusetts, HCSC and Molina. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.